-
Director plans to put Val Kilmer back on screen thanks to AI
-
Social media addiction trial jury deliberations continue
-
Messi scores 900th career goal in Inter Miami cup clash
-
Barcelona, Liverpool, Bayern and Atletico reach Champions League quarter-finals
-
Tudor impressed by 'improved' Spurs despite Champions League exit
-
PSG will not relish Liverpool reunion, says Slot
-
Kane says Bayern 'don't fear anyone' ahead of Real clash
-
Venezuelan leader sacks defense minister, a Maduro stalwart
-
Kane and Bayern swat aside Atalanta to set up Real clash
-
Thailand's new parliament set to elect Anutin as PM
-
Atletico survive Spurs scare to reach Champions League quarters
-
Liverpool thrash Galatasaray to reach Champions League quarters
-
Costa Rica cuts ties with Cuba, closes embassy in Havana
-
Music popstar will.i.am meshes AI and 'micromobility'
-
US Fed Chair says 'no intention' of leaving board while probe ongoing
-
Iran targets Gulf energy sites after intel chief killed
-
Colombia detains alleged mastermind of Ecuadoran candidate assassination
-
Costa Rica closes Havana embassy, tells Cuba to withdraw diplomats
-
NY's New Museum returns contemporary to heart of Manhattan
-
Cesar Chavez, icon of US labor movement, accused of serial sex abuse: report
-
Barcelona demolish Newcastle 7-2 to reach Champions League quarters
-
Trump nominee for Homeland Security chief grilled at fiery Senate hearing
-
First international aid convoy arrives in crisis-hit Cuba
-
Eight killed during Rio police operation, including drug kingpin
-
Iran suffers new blow as Israel kills intel chief
-
Slovakia curbs diesel sales, ups prices for foreigners
-
Oscar-winner Sean Penn meets troops in frontline Ukraine
-
Thousands rally in Istanbul to mark year since mayor's arrest
-
WNBA, players union agree 'transformative' labor deal: official
-
US Fed holds rates unchanged over 'uncertain' Iran war implications
-
Senegal govt calls for investigation into Cup of Nations decision
-
From Faraja to Sepah: Iran's multiple security forces
-
Billionaire Dyson buys 50 percent stake in Bath rugby
-
Senegal demands 'corruption' probe over AFCON decision as Morocco defend appeal
-
The platypus is even weirder than thought, scientists discover
-
PSG's Barcola ruled out for several weeks with ankle injury
-
Colombia detains suspect in 2023 killing of Ecuador politician
-
Iran condemned as UN maritime body holds emergency talks on Mideast shipping
-
Iraqi Kurdish shepherds stoic in face of yet another war
-
Iran women's football team return after asylum tussle
-
US launches new era of drug war with Latin American allies
-
How many cargo ships are passing Hormuz strait?
-
'Free France': Macron reveals name of Europe's largest warship
-
Oil surges as Iran gas facilities hit, stocks slide
-
Foreign press group slams Israeli police for breaking journalist's wrist
-
McIlroy happy with back injury recovery as Masters looms
-
Vinicius 'should be loved by everyone' says Donnarumma after celebration row
-
Iran was not rebuilding nuclear enrichment, US intelligence finds
-
Carrick urges England boss Tuchel to call up United trio
-
Three sporting champions to be stripped of titles for non-doping reasons
BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple
Patients can access meds and labs in a single visit
AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today that it will launch a GLP-1 test panel at over 25 Austin and Temple BetterWay collection locations including Sam's Club and Peoples Rx pharmacies-pairing GLP-1 prescriptions, including Wegovy's new oral GLP-1 option, with BetterWay's patient-preferred fingertip blood collection.
The FDA's recent approval of Novo Nordisk's Wegovy® pill-the first oral GLP-1 for weight loss-further expands access with a convenient, affordable option that is particularly suitable for needle-averse patients.
Blood testing is recommended for GLP-1 users to track metabolic shifts, weight loss, and side effects like blood sugar changes, enabling safer therapy management. BetterWay's launch now enables patients an affordable, convenient one-stop solution.
The BetterWay GLP-1 Test Panel features hemoglobin A1c, lipid panel, comprehensive metabolic panel (CMP) and TSH. In total, the panel includes 29 tests that support safe, informed use of GLP-1 medications by helping providers and patients assess baseline health and ongoing response.
Patients can order the panel for themselves for $98, plus a $4 clinician-oversight fee and can use their FSA/HSAs. The panel can also be ordered by a provider and is covered by some health insurance plans. Customer-initiated orders include a special GLP-1 discount code for testing.
"Retail pharmacies are now a preventive health hub: shop, consult pharmacists, get convenient blood tests, and manage GLP-1s seamlessly at the same locations. This defines a modern care experience where diagnostics, therapeutics, and pharmacy services work together to make preventive care part of everyday life," said David Stein, CEO of Babson Diagnostics.
About BetterWay Blood Testing by Babson Diagnostics
BetterWay™ is blood testing reimagined-patient-friendly fingertip blood collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing. Babson was named 2024 Medtech Company of the Year by MD + DI, 2025 SXSW Innovation Award winner for Health & Biotech, and one of Fast Company's 2025 Most Innovative Companies in Healthcare. For more information, please visit BetterWay.com or connect with us on Instagram or LinkedIn.
Media Contact:
Jo Detavernier
Razor Sharp PR
210-803-2097
[email protected]
# # #
SOURCE: BetterWay Blood Testing
View the original press release on ACCESS Newswire
Ch.Havering--AMWN